MACUGEN (pegaptanib sodium)
NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
EYETECH INC.
All drugs.
Search drugs by brand or generic name, or refine the directory by prescription status, class, indication, manufacturer, and specialty.
Enter at least 3 characters to search the full directory.
Results
MACUGEN (pegaptanib sodium)
NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
VALEANT
EYLEA (aflibercept)
OPHTHALMIC - MACULAR DEGENERATION AGENTS · DIABETIC RETINOPATHY ·+4
Regeneron Pharmaceuticals, Inc.
VISUDYNE (verteporfin)
CHOROIDAL NEOVASCULARIZATION ·+3
VALEANT
LUCENTIS (ranibizumab)
OPHTHALMIC - MACULAR DEGENERATION AGENTS · DIABETIC RETINOPATHY ·+5
GENENTECH
VISUDYNE (verteporfin)
OPHTHALMIC - PHOTODYNAMIC THERAPY AGENTS · CHOROIDAL NEOVASCULARIZATION ·+3
Bausch Health US
MACUGEN (pegaptanib sodium)
NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
Bausch Health US
BEOVU (brolucizumab-dbll)
OPHTHALMIC - MACULAR DEGENERATION AGENTS · NEOVASCULAR AGE-RELATED MACULAR DEGENERATION ·+1
Novartis Pharmaceuticals
SUSVIMO (ranibizumab)
OPHTHALMIC - MACULAR DEGENERATION AGENTS · DIABETIC RETINOPATHY ·+2
GENENTECH
VABYSMO (faricimab-svoa)
OPHTHALMIC - MACULAR DEGENERATION AGENTS · NEOVASCULAR AGE-RELATED MACULAR DEGENERATION ·+2
GENENTECH
CIMERLI (ranibizumab-eqrn)
DIABETIC RETINOPATHY ·+5
COHERUS BIOSCIE
EYLEA HD (aflibercept)
OPHTHALMIC - MACULAR DEGENERATION AGENTS · DIABETIC RETINOPATHY ·+3
Regeneron Pharmaceuticals, Inc.
PAVBLU (aflibercept-ayyh)
OPHTHALMIC - MACULAR DEGENERATION AGENTS · DIABETIC RETINOPATHY ·+3
AMGEN
CIMERLI (ranibizumab-eqrn)
OPHTHALMIC - MACULAR DEGENERATION AGENTS · DIABETIC RETINOPATHY ·+5
SANDOZ
BYOOVIZ (ranibizumab-nuna)
OPHTHALMIC - MACULAR DEGENERATION AGENTS · CHOROIDAL NEOVASCULARIZATION ·+3
HARROW EYE, LLC
BEOVU (brolucizumab-dbll)
OPHTHALMIC - MACULAR DEGENERATION AGENTS · NEOVASCULAR AGE-RELATED MACULAR DEGENERATION ·+1
Novartis Pharmaceuticals
VISUDYNE (verteporfin)
OPHTHALMIC - PHOTODYNAMIC THERAPY AGENTS · CHOROIDAL NEOVASCULARIZATION ·+3
BAUSCH & LOMB P
NUFYMCO (ranibizumab-leyk)
OPHTHALMIC - MACULAR DEGENERATION AGENTS · DIABETIC RETINOPATHY ·+4
ZYDUS PHARMACEU
YESAFILI (aflibercept-jbvf)
OPHTHALMIC - MACULAR DEGENERATION AGENTS · DIABETIC RETINOPATHY ·+3
BIOCON BIOLOGIC
LYTENAVA (bevacizumab-vikg)
OPHTHALMIC - MACULAR DEGENERATION AGENTS · NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
OUTLOOK THERAPE
ENZEEVU (aflibercept-abzv)
OPHTHALMIC - MACULAR DEGENERATION AGENTS · DIABETIC RETINOPATHY ·+3
SANDOZ